Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | sphingosine-1-phosphate receptor 3 | Starlite/ChEMBL | References |
Homo sapiens | sphingosine-1-phosphate receptor 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.008 | 0.4752 | 0.6357 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.1592 | 0.0823 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0075 | 0.4361 | 0.5834 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.008 | 0.4752 | 0.6337 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.005 | 0.2228 | 0.2941 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0024 | 0.0042 | 0.0056 |
Loa Loa (eye worm) | hypothetical protein | 0.0126 | 0.8643 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0075 | 0.4361 | 0.5834 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0112 | 0.7476 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.007 | 0.3948 | 0.3948 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0075 | 0.4361 | 0.5834 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.008 | 0.4752 | 0.6337 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0062 | 0.3311 | 0.443 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0054 | 0.2588 | 0.3461 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.008 | 0.4752 | 0.6357 |
Mycobacterium ulcerans | polyketide synthase | 0.008 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0026 | 0.0229 | 0.0306 |
Onchocerca volvulus | 0.013 | 0.9025 | 0.9285 | |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0075 | 0.4361 | 0.581 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0075 | 0.4361 | 0.5834 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0062 | 0.3311 | 0.4398 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0075 | 0.4361 | 0.5834 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.007 | 0.3948 | 0.3889 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.008 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.008 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0112 | 0.7476 | 1 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0112 | 0.7476 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.005 | 0.2228 | 0.2981 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0073 | 0.4168 | 0.5576 |
Mycobacterium ulcerans | polyketide synthase | 0.0075 | 0.4361 | 0.5834 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.008 | 0.4752 | 0.6337 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0073 | 0.4168 | 0.5576 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0075 | 0.4361 | 0.5834 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0075 | 0.4361 | 0.581 |
Loa Loa (eye worm) | fatty acid synthase | 0.0074 | 0.4277 | 0.4318 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.008 | 0.4752 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0043 | 0.1644 | 0.2199 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.005 | 0.2228 | 0.2981 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0024 | 0.0042 | 0.0056 |
Mycobacterium ulcerans | thioesterase | 0.0062 | 0.3311 | 0.443 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.006 | 0.3131 | 0.4188 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0075 | 0.4361 | 0.4361 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0075 | 0.4361 | 0.5834 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0135 | 0.9416 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.006 | 0.3131 | 0.4155 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.003 | 0.061 | 0.0817 |
Mycobacterium ulcerans | thioesterase TesA | 0.0062 | 0.3311 | 0.443 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.007 | 0.3948 | 0.528 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.008 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0061 | 0.3214 | 0.4299 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.006 | 0.3131 | 0.4188 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0112 | 0.7476 | 1 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0049 | 0.2149 | 0.2574 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0053 | 0.2547 | 0.3708 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 1800 nM | Agonist activity at human recombinant S1P1 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis | ChEMBL. | 24266709 |
EC50 (functional) | > 10000 nM | Agonist activity at human recombinant S1P3 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 1 hr by topcount scintillation counting analysis | ChEMBL. | 24266709 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.